David F Hale's Net Worth
$405 Thousand
Who is David F Hale?
David F Hale does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Oncternal Therapeutics, Inc., Conatus Pharmaceuticals Inc, Dermata Therapeutics, Inc., BIOCEPT INC, MICROMET, INC., SANTARUS INC, Pernix Sleep, Inc., and METABASIS THERAPEUTICS INC.
SEC CIK
David F Hale's CIK is 0001024004
Past Insider Trading and Trends
2009 was David F Hale's most active year for acquiring shares with 24 total transactions. David F Hale's most active month to acquire stocks was the month of May. 2012 was David F Hale's most active year for disposing of shares, totalling 13 transactions. David F Hale's most active month to dispose stocks was the month of February. 2006 saw David F Hale paying a total of $128,998.30 for 574,526 shares, this is the most they've acquired in one year. In 2012 David F Hale cashed out on 824,848 shares for a total of $3,933,332.37, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Oncternal Therapeutics, Inc. (ONCT) Snapshot price: $4.47
InvestorDavid F Hale owns 714 units of Common Stock which is worth $3,191.58. From 2019 to 2024 David F Hale acquired a total of 714 shares in Oncternal Therapeutics, Inc. at a cost of $6,454.56.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +3.33% | 980 |
$9.04 | $8,859.20 | 30.39K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| -0.51% | -3.67K |
$4.75 | -$17,427.75 | 713.15K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +2.49% | 17.41K |
—
|
—
| 716.82K |
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
∞
| 717.75K |
—
|
—
| 717.75K |
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Conatus Pharmaceuticals Inc (HSTO) Snapshot price: $0.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dermata Therapeutics, Inc. (DRMA) Snapshot price: $1.59
InvestorDavid F Hale owns 75,720 units of Common Stock which is worth $120,394.80. From 2021 to 2024 David F Hale acquired a total of 72,062 shares in Dermata Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +66.18% | 30.16K |
—
|
—
| 75.72K |
Oct 6
| |||
Form 4
| +138.26% | 26.44K |
—
|
—
| 45.56K |
Jul 7
| |||
Form 4
| +422.80% | 15.47K |
—
|
—
| 19.12K |
Apr 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +123.32% | 314K |
—
|
—
| 568.64K |
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOCEPT INC (BIOCQ) Snapshot price: $0.01
ChairmanDavid F Hale owns 796 units of Common Stock which is worth $7.96. In the year 2014 David F Hale filed a total of 19 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.99% | -445.00 |
$4.07 | -$1,807.35 | 4.01K |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 4
| -20.66% | -1.16K |
$0.56 | -$644.02 | 4.46K |
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30 - Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
| +260.29% | 90.91K |
$1.10 | $99,999.90 | 125.83K |
Jun 16 - Oct 19
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +56.59% | 50K |
$1.00 | $50,000.00 | 138.36K |
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +260.78% | 63.87K |
—
|
—
| 88.36K |
Nov 9
| |||
Form 4
| +140.00% | 14.29K |
—
|
—
| 24.49K |
Aug 24
| |||
Form 4
| +73.30% | 40K |
$1.25 | $50,000.00 | 94.57K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +638.53% | 47.18K |
$10.00 | $471,810.00 | 54.57K |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MICROMET, INC. No price found
President and CEODavid F Hale owns 139,062 units of Common Stock. From 2006 to 2010 David F Hale acquired a total of 220,594 shares in MICROMET, INC. at a cost of $142,832.24.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
| -100.00% | -121.95K |
$11.00 | -$1,341,461.00 |
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
| -0.95% | -1.00K |
—
|
—
| 103.79K |
May 19
| |||
Form 4
| -3.68% | -4.00K |
—
|
—
| 104.79K |
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| -21.62% | -30.00K |
$7.24 | -$217,200.00 | 108.79K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
| +0.45% | 629 |
$2.12 | $1,333.48 | 139.06K |
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
∞
| 18.16K |
$2.69 | $48,863.85 | 18.16K |
Jun 22
| |||
Form 4
| +1.92% | 2.6K |
$2.69 | $6,999.38 | 138.43K |
Jun 19
| |||
Form 4
| +169.00% | 85.34K |
$2.84 | $5,501.08 | 135.83K |
Jan 4 - Mar 21
| |||
Form 4
| +5.02% | 2.41K |
$2.90 | $7,000.60 | 50.49K |
Dec 7
| |||
Form 4
| +7.33% | 3.28K |
$2.64 | $8,664.48 | 48.08K |
Oct 25
| |||
Form 4/A
| +214.73% | 30.56K |
$6.63 | $56,666.61 | 44.8K |
May 5
| |||
Form 4
| +71.58% | 30.56K |
$6.63 | $56,666.61 | 73.27K |
May 5
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
∞
| 42.7K |
—
|
—
| 42.7K |
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
∞
| 22.5K |
—
|
—
| 22.5K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
∞
| 49.41K |
—
|
—
| 49.41K |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||